Results 61 to 70 of about 3,665 (206)

Pemphigus foliaceus in a sheep

open access: yesSemina: Ciências Agrárias, 2019
Pemphigus foliaceus (PF) is an autoimmune disease of the skin and is the most common form of pemphigus in domestic animals. This work reports a case of pemphigus foliaceus in a Santa Inês hair sheep.
Aline Antas Cordeiro Cavalcanti   +6 more
doaj   +3 more sources

Pemphigus Foliaceus—Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report

open access: yesFrontiers in Medicine, 2018
Pemphigus foliaceus is an autoimmune skin disease mediated by autoantibodies directed against desmoglein-1 located in the upper epidermal layer. Rituximab, a monoclonal anit-CD20 antibody depleting b-cells, offers an effective treatment possibility for ...
Magdalena Kraft, Margitta Worm
doaj   +1 more source

Navigating the Complexities of Pemphigus Vulgaris: A Comprehensive Iranian Study

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
We conducted a cross‐sectional analysis of 63 patients diagnosed with pemphigus vulgaris, confirmed by biopsy. Information was collected via telephone interviews. The research aimed to assess the demographic characteristics, initial symptoms, diagnosis delays, and treatment outcomes of the participants.
Delaram Moosavi   +7 more
wiley   +1 more source

Similarities and differences between Pemphigus Foliaceus and Pemphigus Vulgaris regarding pathogenesis and prognosis [PDF]

open access: yes, 2011
Pemphigus foliaceus och pemphigus vulgaris är två mycket allvarliga, autoimmuna blåsbildande sjukdomar som kan drabba bla. hund. Blåsorna övergår till erosioner, ulcerationer och krustor allt eftersom sjukdomen fortskrider.
Lundberg, Zandra
core  

Localized Pemphigus Foliaceus with Unilateral Facial Involvement

open access: yes, 2014
Pemphigus foliaceus is a superficial vesiculobullous disease that typically presents with widespread lesions. Localized presentations are less frequent, and they typically occur in middle-aged patients, following exposure to topical medications, and ...
A.D. Maderal   +7 more
core   +1 more source

Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas   +3 more
wiley   +1 more source

Programmed cell death 1 gene (PDCD1) polymorphism and pemphigus foliaceus (fogo selvagem) disease susceptibility

open access: yesGenetics and Molecular Biology, 2007
Pemphigus foliaceus, also known as fogo selvagem, is an autoimmune disease of the epidermis characterized by superficial blisters and antibodies against desmoglein 1.
Karin Braun-Prado   +1 more
doaj   +1 more source

NUDT15 and TPMT Pharmacogenomic Testing for Azathioprine‐Induced Adverse Reactions in Immune‐Mediated Skin Diseases

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Background While thiopurine S‐methyltransferase (TPMT) variants are known to correlate with azathioprine (AZA)‐induced adverse effects (AEs), nucleoside diphosphate‐linked moiety X Motif 15 (NUDT15) variants were reported to be more prevalent and correlated with AZA toxicity in Asians.
Koramon Phuwaraks   +10 more
wiley   +1 more source

Juvenile pemphigus foliaceus. [PDF]

open access: yesThe British journal of dermatology, 1998
A 7-year-old girl with generalized erythematous, scaling plaques and vesiculobullous lesions on the extremities was diagnosed as having pemphigus foliaceus. Lesional direct immunofluorescence revealed intercellular IgG, IgA and C3 deposition. The patient's serum gave positive reactions against one epitope of desmoglein 3 and the epitope of desmoglein 1
Mehravaran Mehrdad   +6 more
openaire   +2 more sources

JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy